The in vitro micronucleus (MN) test (OECD TG 487) has become the gold standard in various regulatory silos for assessing compounds for their potential to cause clastogenicity. Its main advantages are the reproducibility and robustness, as well as the ability to investigate both structural and numerical chromosome damage, i.e. clastogenicity and aneuploidy. A disadvantage, however, can be seen in the resource-intensive microsco...

The European Union (EU) Battery Regulation aims to establish a circular battery production and sets minimum battery material recycled targets for new batteries from post‐production and post‐consumer waste batteries. However, it is uncertain whether these targets can be met due to dynamic market developments and if their compliance results in environmental benefits. Therefore, this study examines the circular battery production...

The use of novel battery technologies in short‐haul electric aircraft can support the aviation sector in achieving its goals for a sustainable development. However, the production of the batteries is often associated with adverse environmental and socio‐economic impacts, potentially leading to burden shifting. Therefore, this paper investigates alternative technologies for lithium–sulfur all‐solid‐state batteries (LiS‐ASSBs) i...

Citizen science (CS) can foster transformative impact for science, citizen empowerment and socio-political processes. To unleash this impact, a clearer understanding of its current status and challenges for its development is needed. Using quantitative indicators developed in a collaborative stakeholder process, our study provides a comprehensive overview of the current status of CS in Germany, Austria and Switzerland. Our onl...

Genetic variations affecting the course of depressive symptoms in patients with coronary artery disease (CAD) have not yet been well studied. Therefore, we set out to investigate whether distinct haplotypes of the two insertion/deletion polymorphisms in the serotonin-transporter-linked polymorphic region ( 5-HTTLPR ) and the angiotensin I-converting enzyme ( ACE ) gene located on chromosome 17 can be identified as risk factors...